Discussing Real-World Ruxolitinib and Corticosteroid Treatment Patterns in Patients with cGVHD

Video content above is prompted by the following:

• Which patients with chronic graft-vs-host disease (cGVHD) do you treat with ruxolitinib in your clinical practice?
• Do you use corticosteroids concurrently with ruxolitinib?
• What were this abstract’s study design and methods, and why was it important to investigate for cGVHD management?
• What were the key efficacy and safety results seen in this abstract?
• Do these results align with what you see in your clinical practice?